Surrozen, Inc. (SRZNW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jun 24Jun 29Jul 2Jul 9Jul 15Jul 24Jul 30Aug 7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.3x

Market Cap

$12856.50

MomentumView details →

1D Return

−60.53%

YTD Return

−92.50%

RSI (14)

38.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.3x

Market Cap

$12856.50

RSI (14)

38.0

MomentumView details →

1D Return

−60.53%

YTD Return

−92.50%

ProfitabilityView details →

Gross Margin

99.44%

Net Margin

−2885.33%

EBITDA Margin

−2883.40%

ROE (TTM)

151.89%

ROA (TTM)

−287.29%

Asset Turnover

0.10x

GrowthView details →

Revenue YoY

−8.79%

EPS YoY

—

FCF YoY

−86.81%

Revenue CAGR 3Y

−34.72%

EPS CAGR 3Y

−49.38%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.41

EPS Surprise

68.17%

Beats (12Q)

2/12

Next Q EPS Est

—

Avg Surprise (4Q)

−730.24%

Rev Surprise

970.09%

Capital & dividendView details →

Debt/Equity

−0.03x

Current Ratio

12.14x

Quick Ratio

12.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

11.51M

Net Income (TTM)

−332.13M

Op. CF (TTM)

−34.76M

Latest newsMore news →

No recent news for SRZNW.

Similar companies

Psyence Biomedical Ltd. WarrantPBMWW Syros Pharmaceuticals, Inc.SYRS Silexion Therapeutics Ltd.SLXNW Aditxt, Inc.ADTX Cardio Diagnostics Holdings, Inc.CDIOW Moolec Science S.A.MLECW Find similar companies →

Latest newsMore news →

No recent news for SRZNW.